Medicamen Biotech Ltd.
Fundamentals
- Market cap
- ₹310 cr
- P/E
- 32.10×
- ROE
- 3.08%
- Debt / equity
- 0.16
- Div yield
- 0.44%
- 52-week range
- 216.95 — 447.65
Company snapshot
Medicamen Biotech Ltd.
Pharmaceuticals
₹350 cr
P/E 36.28×
Latest quarter · Mar 2026
Sales₹61 cr
Net profit₹4 cr
Op. margin+9.0%
EPS₹2.84
Strength & growth
Debt / equity0.16×
Current ratio2.11×
Sales CAGR+11.4%
EPS CAGR−1.4%